Gladstone spacer GICD
 
 
Supporting Gladstone
Publications

Original Articles (peer reviewed)

  1. Pintchovski SA, Peebles CL, Kim HJ, Verdin E, Finkbeiner S. (2009) The serum response factor and a putative novel transcription factor regulate expression of the immediate-early gene Arc/Arg3.1 in neurons. J. Neurosci. 29:1525–1537.

  2. Mitra S, Tsvetkov A, Finkbeiner S. (2009) Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in Huntington's disease. J. Biol. Chem. 284:4398–4403.

  3. Mitra S, Finkbeiner S. (2008) The ubiquitination-proteasome pathway in Huntington’s disease. ScientificWorldJournal 8:421–433.

  4. Palop JJ, Chin J, Roberson ED, Wang J, Twin MT, Bien-Ly N, Yoo J, Ho KO, Yu G-Q, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L. (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron 55:697–711.

  5. Rao V, Carter S, Finkbeiner S. (2007) NMDA and AMPA receptors: Old channels, new tricks. Trends Neurosci. 30:284–291.

  6. Finkbeiner S, Cuervo AM, Morimoto RI, Muchowski PJ. (2006) Disease-modifying pathways in neurodegeneration. J. Neurosci. 26:10349–10357.

  7. Rao VR, Pintchovski SA, Peebles, CL, Mitra S, Finkbeiner S. (2006) AMPA receptors regulate transcription of the plasticity-related immediate early gene Arc. Nat. Neurosci. 9:887–895.

  8. Bradley J, Rao VR, Wang J, Carter S, Finkbeiner S. (2006) Splice variants of the NR1 subunit differentially induce NMDA receptor-dependent gene expression. J. Neurosci. 26:1065–1076.

  9. Peters-Libeu C, Newhouse Y, Krishnan P, Cheung K, Brooks E, Weisgraber K, Finkbeiner S. (2005) Crystallization and diffraction properties of the Fab fragment of 3B5H10, an antibody specific for disease-causing polyglutamine stretches. Acta Crystallograph. Sect. F Struct. Biol. Cryst. Commun. 61:1065–1068.

  10. Arrasate M, Finkbeiner S. (2005) Automated microscope system for determining factors that predict neuronal fate. Proc. Natl. Acad. Sci. USA 102:3840–3845.

  11. Arrasate M, Mitra S, Schweitzer E, Segal M, Finkbeiner S. (2004) Inclusion body formation reduces the levels of mutant huntingtin and the risk of neuronal death. Nature 431:805–810.

  12. Humbert S, Bryson EA, Cordelières FP, Connors NC, Datta SR, Finkbeiner S, Greenberg ME, Saudou F. (2002) The IGF-1/Akt pathway is neuroprotective in Huntington’s disease and involves huntingtin phosphorylation by Akt. Dev. Cell 2:831–837.

  13. Bradley J, Finkbeiner S. (2002) An evaluation of specificity in activity-dependent gene expression in neurons. Prog. Neurobiol. 67:469–477.

  14. Finkbeiner S. (2001) New roles for introns: Sites of combinatorial regulation of Ca2+-and cyclic AMP-dependent gene transcription. Sci. STKE 94:PE1–PE4.

  15. Finkbeiner S. (2000) CREB couples neurotrophin signals to survival messages. Neuron 25:11–14.

  16. Saudou F, Finkbeiner S, Devys D, Greenberg ME. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55–66.

  17. Finkbeiner SM, Greenberg ME. (1998) Ca2+-regulated neuronal gene expression. J. Neurobiol. 37:171–189.

  18. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20:709–726.

  19. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME. (1997) CREB: A major mediator of neuronal neurotrophin responses. Neuron 19:1031–1047.

  20. Finkbeiner S, Greenberg ME. (1996) Ca2+-dependent routes to Ras: Mechanisms for neuronal survival, differentiation, and plasticity? Neuron 16:233–236.

  21. van den Pol AN, Finkbeiner SM, Cornell-Bell AH. (1992) Calcium excitability and oscillations in suprachiasmatic nucleus neurons and glia in vitro. J. Neurosci. 12:2648–2664.

  22. Finkbeiner S. (1992) Calcium waves in astrocytes-filling in the gaps. Neuron 8:1101–1108.

  23. Renzi R, Finkbeiner S. (1991) Ciprofloxacin interaction with sodium warfarin: A potentially dangerous side effect. Am. J. Emerg. Med. 9:551–552.

  24. Goldman RS, Finkbeiner SM, Smith SJ. (1991) Endothelin induces a sustained rise in intracellular calcium in hippocampal astrocytes. Neurosci. Lett. 123:4–8.

  25. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. (1990) Glutamate induces calcium waves in cultured astrocytes: Long-range glial signaling. Science 247:470–473.

  26. Keana JF, McBurney RN, Scherz MW, Fischer JB, Hamilton PN, Smith SM, Server AC, Finkbeiner S, Stevens CF, Jahr C, Weber E. (1989) Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methyl-D-aspartate receptor antagonists with neuroprotective properties. Proc. Natl. Acad. Sci. USA 86:5631–5635.

  27. Finkbeiner S, Stevens CF. (1988) Applications of quantitative measurements for assessing glutamate neurotoxicity. Proc. Natl. Acad. Sci. USA 85:4071–4074.


Other Publications

  1. Peebles CL, Finkbeiner S. (2007) RNA back in play. Nat. Neurosci. 10:1083–1084.

  2. Mitra S, Finkbeiner S. (2007) Huntington’s disease, ubiquitination and proteasomes. TSW Neurol. Solicited.

  3. Brooks L, Arrasate, M, Cheung K, Finkbeiner S. (2004) Using antibodies to analyze polyglutamine stretches. In: Methods in Molecular Biology: Triplet Repeat Protocols. Ed., Kohwi Y. Totowa: Humana Press, pp. 277:103–128.

  4. Rao VR, Finkbeiner S. (2003) Secrets of a secretase: N-cadherin proteolysis regulates CBP function. Cell 144:533–535.

  5. Finkbeiner S. (2000) Calcium regulation of the brain-derived neurotrophic factor gene. Cell. Mol. Life Sci. 57:394–401.

  6. Curtis J, Finkbeiner S. (1999) Sending signals from the synapse to the nucleus: Possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth. J. Neurosci. Res. 58:88–95.

  7. Finkbeiner S, Dalva MB. (1998) To fear or not to fear: What was the question? A potential role for Ras-GRF in memory. Bioessays 20:691–695.

  8. Finkbeiner SM, Greenberg ME. (1998) Ca2+-regulated neuronal gene expression. J. Neurobiol. 37:171–189.

  9. Finkbeiner S, Greenberg ME. (1998) Ca2+ channel-regulated neuronal gene expression. J. Neurobiol. 37:171–189.

  10. Finkbeiner S, Greenberg ME. (1997) Spatial features of calcium-regulated gene expression. Bioessays 19:657–660.

  11. Finkbeiner SM. (1996) Neurotrophins and the synapse. Neuroscientist 2:1–4.

  12. Finkbeiner SM. (1996) Calcium control and modulation. In: Neuroglial Cells. Eds., Kettenmann H, Ransom B. New York: Oxford University Press, pp. 273–288.

  13. Finkbeiner SM. (1995) Ca2+-regulated gene expression: Mechanism for plasticity and neuronal survival. Neuroscientist 1:110–114.

  14. Finkbeiner SM. (1993) Glial calcium. Glia 9:83–104.

  15. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. (1992) Extraneuronal communication. In: Encyclopedia of Neuroscience: Neuroscience Year. Supplement 2. Boston: Birkhaüser, pp. 65–68.

  16. Cornell-Bell AH, Finkbeiner SM. (1991) Ca2+ waves in astrocytes. Cell Calcium 12:185–204.

  17. Goldman RS, Finkbeiner SM. (1988) Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure. N. Engl. J. Med. 319:1224–1225.


Gladstone Home | Cardiovascular Disease | Virology and Immunology | Neurological Disease | Administration | UCSF